Anesthesiology
-
Randomized Controlled Trial Clinical Trial
Naloxone, meperidine, and shivering.
Meperidine, which binds both mu and kappa opioid receptors, is reportedly more effective in treating shivering than are equianalgesic doses of morphine (a nearly pure mu-receptor agonist). Furthermore, butorphanol, a kappa-receptor agonist/antagonist, treats shivering better than does fentanyl, which mostly binds mu receptors. These data indicate that much of meperidine's special antishivering activity may be mediated by its kappa activity. Accordingly, the authors tested the hypothesis that the antishivering activity of meperidine will be minimally impaired by low-dose naloxone (blocking most mu-receptors), but largely prevented by high-dose naloxone (blocking all mu and most kappa receptors). ⋯ These data indicate that the antishivering property of meperidine is not fully mediated by mu-receptors. Although meperidine has well-known nonopioid actions, stimulation of kappa receptors seems a likely alternative explanation for much of the drug's antishivering action.
-
Randomized Controlled Trial Clinical Trial
Determinants of catecholamine and cortisol responses to lower extremity revascularization. The PIRAT Study Group.
Surgical trauma elicits diffuse changes in hormonal secretion and autonomic nervous system activity. Despite studies demonstrating modulation of the stress response by different anesthetic/analgesic regimens, little is known regarding the determinants of catecholamine and cortisol responses to surgery. ⋯ These data indicate that patient factors, such as age and inherent sympathetic responsivity, are important determinants of the catecholamine response to surgery. Modulation of the norepinephrine response by regional anesthesia/analgesia appears to be related, in part, to superior analgesia. The lack of correlation between catecholamine and cortisol secretion indicates that the stress response may consist of discrete systems responding to different stimuli.
-
Randomized Controlled Trial Comparative Study Clinical Trial
Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients.
Succinylcholine has been the agent of choice when clinical conditions require emergency airway protection during a rapid-sequence induction of anesthesia. Rocuronium, a new nondepolarizing muscle relaxant with a brief onset of action, but devoid of the adverse reactions associated with succinylcholine, may be an alternative to succinylcholine. To test this hypothesis, the authors compared rocuronium with succinylcholine and vecuronium for rapid-sequence induction of anesthesia. ⋯ There is a dose-dependent decrease in onset time with rocuronium. The onset times for the two larger doses of rocuronium were similar to that for succinylcholine, but clinical duration of action with rocuronium was significantly longer. The brief onset time achieved with rocuronium indicates that administration of 0.9-1.2 mg/kg is an acceptable alternative to succinylcholine for rapid-sequence induction of anesthesia.
-
Randomized Controlled Trial Clinical Trial
The dose of propofol required to prevent children from moving during magnetic resonance imaging.
Intravenous propofol offers several advantages as an anesthetic for children undergoing magnetic resonance imaging. However, the dose of propofol required to prevent movement during magnetic resonance imaging is likely to be less than that required for surgical anesthesia. ⋯ Following induction of anesthesia with halothane, nitrous oxide, and a 2 mg.kg-1 loading dose of propofol, infusion of propofol at a rate of 100 micrograms.kg-1 x min-1 effectively prevents children from moving during elective magnetic resonance imaging. A transient decrease in arterial oxygen saturation can occur after the initial bolus of propofol. Recovery from anesthesia is rapid and without nausea or vomiting.
-
Randomized Controlled Trial Clinical Trial
Efficacy of oral clonidine premedication in children.
Clonidine, an alpha 2-adrenoceptor agonist, has been shown to be effective as a preanesthetic medication in adults. The current study was designed to investigate the efficacy of two doses of oral clonidine as a premedicant preceding oral atropine in children. ⋯ These data indicate that, even in pediatric surgery, the combination of 4 micrograms/kg and 0.03 mg/kg oral clonidine is an effective premedication. However, the safety and optimal dose of clonidine in this setting remain to be determined.